chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient took nap and around 7pm legs collapsed. Patient fell down on face, on legs lost feeling and had pain. Called clinic and went to ER and did some testing that day and also days later. That month had neck surgery in the same facility. Problems with legs still continued; legs very week, can't do leg lifts. Right deltoid feels like the needle broke off in there; pain wakes him up at night when he rolls over. Patient has gone to clinic on multiple occasions since then. Patients reports problems getting copies of records and appointments for about a year or so. Was referred to Physical Therapy and had about 7 sessions. Currently, takes ALEVE about 2 times a day. Feels condition not improving and it is actually getting worse-both on legs and shoulder. Loss feeling in your fingertips, arm pretty much paralyzed, pain in elbow is about an 8 and in shoulder is about a 9.
Patient reported the event to her supervisor by email on 6-19-18. I was notified at 4pm on 6-19-18 of the email and contacted the patient by phone. She reported that she began having symptoms at around 9am on 6-18-18 which were "chest hurting", and cough. She stated that she did not have difficulty breathing but it was harder to breath than normal. She stated she was no longer having pain, but still coughing a little. The cough sounded dry and hoarse. She denied all other symptoms. I instructed that she see a physician to be evaluated and she declined. She agreed to go to Clinic if pain returned or cough did not continue to improve. Instructed to call back with any questions or concerns or go to Clinic if after our hours.
My dermal fillers on the left side of my face are hot and swelling up. It is very painful
Vaccine was pre-drawn in syringes prior to administration which is not recommended per CDC as there were no stability data for pre-drawn syringes. Was in pre-drawn syringes for about an hour. No adverse effect specified by the patient.
PATIENT CAME IN WITH REDNESS AT THE INJECTION SITE AS WELL AS RADIATING REDNESS 4-5 INCHES IN DIAMETER. SHE STATES THAT THIS HAD HAPPENED TO HER IN THE PAST WHEN SHE RECEIVED A PNEUMOVAX AND FLU SHOT TOGETHER LAST YEAR. I SUGGESTED THAT SHE WATCH THE MARGINS TO MAKE SURE THAT IT DOESN'T GROW LARGER AND THAT SHE SHOULD SEE HER DOCTOR TO DETERMINE TREATMENT. PREVIOUS TREATMENT FOR A SIMILAR REACTION WITH ANTIBIOTICS WORKED. AT THE TIME THE DOCTOR HAD DETERMINED THAT IT WAS CELLULITIS BROUGHT ON BY THE VACCINATION.    I WILL FOLLOW UP WITH THE PATIENT ON THURSDAY TO MAKE SURE SHE IS OKAY AND IF SHE WAS ABLE TO SPEAK WITH HER PHYSICIAN.
Patient visited clinic 9/26/22 and spoke with supervisor and supervisor reported information to this writer.  Report included c/o arm soreness, difficulty lifting arm  that started 9/25/22; patient was advised to follow up with PMD. This writer contacted patient 9/27/22 and 10/7/22 with no response.
At approximately 1630, patient was getting ready to leave the vaccine clinic. She advised writer that she had a strong metallic taste in her mouth. It started 10-15 minutes after the injection. Denied all other symptoms that could be considered a side effect or allergic reaction to the vaccination. Advised patient she could stay later for further observation. Patient declined to stay. She felt fine otherwise. Patient was further advised if develops shortness of breath, or throat tightening to call 911 immediatley. Patient verbalized understanding. She indicated that she does have an epi pen due to allergies and will use it if necessary.   Called patient at approximately 1830. She informed writer that she did have the strong Metallic taste in her mouth that started 15 minutes after the immunization and it lasted for about 1 hour.  She reports that she was slightly light headed once she got home. Patient is not sure if it is due to starting night shift last night or if it was from the vaccine. Patient encouraged to increase her water intake. She was also encouraged to call PCP's office if light headedness does not completely resolved. If develops life threatening symptoms, to call 911.  She was in agreement with plan.  Writer will completed VAERS report tomorrow.
Heart attack; Pericarditis; stroke; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID:.  A male patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MYOCARDIAL INFARCTION (medically significant), outcome "unknown", described as "Heart attack"; PERICARDITIS (medically significant), outcome "unknown"; CEREBROVASCULAR ACCIDENT (medically significant), outcome "unknown", described as "stroke".  Clinical course: My family will never get another Covid shot. Husband and myself suffered heart attack, pericarditis and stroke too close to vaccines. Not likely coincidence in healthy seniors.  The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : UM-PFIZER INC-PV202300185453 Same drug and AE different patient;
Initial report received from a Non healthcare professional via consumer on 26 September 2013. A 72 year(s) old female, patient received FLUZONE on 24-Sept-2013; i.e. same day the patient also received the PNEUMOCOCCAL VACCINE. On 24-Sep-2013; 1.e same day the patient experienced mild fever (100.2 degree F), achy, sore throat, and stuffy nose. She also reports very itchy inside her ears. The patient medical history and concomitant medications were not reported. The patient's outcome was not reported. Document held by sender: none
5/1/08 Patient received her 2 months shot.  Patient was intermittently irritable for the next 5-7 days.  More treated patient with Motrin.
Bad flu symptoms; This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a 62-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was unknown.   It was unknown if the reporter considered the influenza-like symptoms to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient stated that, after vaccination with dose of Shingrix, had bad flu symptoms. The patient wanted to know whether she will experience same after 2nd dose of Shingrix.
Severe headache, fever of 100 degrees, asthma symptoms (cough, difficulty in catching breath), bloodshot eyes.
Employee reporting increased redness and swelling to left upper arm after receiving flu vaccine 2 days prior, evaluated by ER NP and provided with prescription for KEFLEX 500 mg four times a day and to apply warm compresses to area. Employee reported all symptoms resolved as of 9/29/2018.
itching really bad; arms, tights trunk, and everything except my head/itch; the itch went more to a tingling; never received the second dose of the Moderna COVID-19 Vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching really bad), PRURITUS (arms, tights trunk, and everything except my head/itch), PARAESTHESIA (the itch went more to a tingling) and PRODUCT DOSE OMISSION ISSUE (never received the second dose of the Moderna COVID-19 Vaccine) in a 63-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048C21A) for COVID-19 vaccination.     Concurrent medical conditions included Shellfish allergy.    On 02-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Aug-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (never received the second dose of the Moderna COVID-19 Vaccine). On an unknown date, the patient experienced PRURITUS (itching really bad), PRURITUS (arms, tights trunk, and everything except my head/itch) and PARAESTHESIA (the itch went more to a tingling). The patient was treated with DEXAMETHASONE for Itching, at an unspecified dose and frequency; HYDROCODONE for Itching, at an unspecified dose and frequency; METHYLPREDNISOLONE (MEDROL [METHYLPREDNISOLONE]) for Itching, at an unspecified dose and frequency and IVERMECTIN for Tingling, at an unspecified dose and frequency. On 02-Aug-2021, PRODUCT DOSE OMISSION ISSUE (never received the second dose of the Moderna COVID-19 Vaccine) had resolved. At the time of the report, PRURITUS (itching really bad), PRURITUS (arms, tights trunk, and everything except my head/itch) and PARAESTHESIA (the itch went more to a tingling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       It was reported that the patient had experienced itching like bug bites on arms, tights trunk everywhere except head, went to urgent care on 21-Aug-2021, doctor suggested that the tingling and heat was internal not external, like a nerve issue. Patient did not received 2nd dose of Moderna COVID-19 vaccine as per the advise of the doctor.  Treatment includes: V Vitamins and nerve support, And Antihistaminic drug. No concomitant medications were reported
36 hours after vaccine, full body hives, intense itching, erythema Placed on 5 day dose of steroids Hives lasted 1 week, resolved
Peripheral coldness, Paraesthesia, Cyanosis, Pyrexia, Influenza like illness, Pain. This case was reported by a nurse practitioner and described the occurrence of cold, tingling, blue extremities in a 20-year old female patient who received hepatitis inactivated and hepatitis B recombinant vaccine (Twinrix). The patient had no known drug allergies and was healthy at the time of administration of Twinrix. On 12 December 2003, the patient received the first dose of Twinrix (lot HAB235A4). At an unspecified time following administration of Twinrix, on 12 December 2003, the patient developed cold, tingly, bluish extremities, a feverish feeling, flu-like symptoms, and achiness. That same day, she was seen at the student health service. As of 12 December 2003, the events were unresolved.
This spontaneous report as received from a healthcare worker refers to a female patient of unknown age. On 27-FEB-2012 the patient was vaccinated with the first dose of GARDASIL intramuscular injection (dose and site of administration were not reported) (lot # 1561AA; exp. date 26-AUG-2014). On 23-APR-2012 the patient was vaccinated with the second dose of GARDASIL intramuscular injection (dose and site of administration were not reported) (lot # 1561AA; exp. date 26-AUG-2014). Over one year after the second dose on 26-AUG-2013, the patient received her third dose of GARDASIL intramuscular injection (site and dose of administration were not reported) (lot # H021346; exp date 01-OCT-2015). No adverse effects were reported. Additional information has been requested.
My dad died 1/1/2022 suddenly and he was perfect fine until he got the vaccine.
His hands got numb, he still has three fingers of his right hand numb; Joints got swollen, had to be in bed.; Pain in every joint of the body, The pain was very strong; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (His hands got numb, he still has three fingers of his right hand numb), JOINT SWELLING (Joints got swollen, had to be in bed.) and ARTHRALGIA (Pain in every joint of the body, The pain was very strong) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Osteoarthritis in January 2021.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (His hands got numb, he still has three fingers of his right hand numb), JOINT SWELLING (Joints got swollen, had to be in bed.) and ARTHRALGIA (Pain in every joint of the body, The pain was very strong). At the time of the report, HYPOAESTHESIA (His hands got numb, he still has three fingers of his right hand numb) had not resolved and JOINT SWELLING (Joints got swollen, had to be in bed.) and ARTHRALGIA (Pain in every joint of the body, The pain was very strong) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The concomitant medications reported included pain medications for back. The treatment information provided included pain medication he usually takes for back pain, he had some extra.
Pt recv vax on 10/28/98; on same day pt exp throbbing/swollen/gray thin pus at vax site
Site: Pain at Injection Site-Medium, Systemic: Fainting / Unresponsive-Severe, Systemic: Seizure-Severe, Additional Details: patient had 3 episodes. 1st: she had severe nausea that morning.2nd : nausea then vomited. 3rd. same say couple hours later, she fainted, unconscious and turned rigid. as she woke up she vomited. f/u with md awaits results
Hashimoto's Disease; Information has been received from a lawyer concerning a case in litigation and refers to a female patient of unknown age. No information regarding the pt's medical history and concomitant medications was reported. On or around 06-JUL-2015, the pt was inoculated with zoster vaccine live (ZOSTAVAX) injection (dose, route of administration, vaccination site, lot # and expiry date were not specified) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). On an unknown date (reported as "a couple of months after"), the pt became increasingly severely fatigued and noticed a small midline anterior neck mass. She sought treatment with her primary care physician and following a multitude of lab tests was diagnosed with Hashimoto's Disease, an autoimmune disorder believed to be triggered by a viral infection/response-including herpes zoster (shingles). The pt underwent extensive medical treatment including thyroid lobectomy. As a direct and proximate result of Company's defective zoster vaccine live (ZOSTAVAX) vaccine, the pt's symptoms have resulted in physical limitations not present prior to using Merck's product. The pt also experienced mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), the pt sustained severe and permanent personal injuries. Further, as a tragic consequence of Company's wrongful conduct, the pt suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of the Company's conduct, the pt had suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of the event was not recovered. The causality was related.  The event of Hashimoto's Disease was considered to be disabling.  Upon internal review, the event of Hashimoto's Disease was determined to be medically significant.
Swelling and redness at immunization site.  Dx in ED with acute postimmunization cellulitis, right shoulder
Muscle pain, joint pain, fatigue, chills, lower left abdominal pain, dizziness, pain in left shoulder and back, trouble walking
Red, itchy rashes and hives that come and go throughout the day on various parts of my body, This is occurring daily, with some days are worse than others. Today is day 23. I have been taking Allegra and Pepcid daily to keep the itching and discomfort under control.
After I got dizzy and immediately laid down.  I developed a headache and had general fatigue which lasted about 3 days
Dizziness; Pain; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received first dose of BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number: unknown, Expiration Date: unknown), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that his dizziness had gone down now 24Mar2021 and his second dose was due Friday, 26Mar2021. It was also stated that the pain had also completely stopped. Outcome of the event dizziness was recovering, pain was recovered.  Information on the lot/batch number has been requested.
Diagnosed with myocarditis on day of admission, found to have elevated troponin levels, currently hospitalized for observation and potential supportive care, however patient with no cardiac compromise and stable. Patient with chest pain that has resolved.
pt recv vax 3FEB97 & 3FEB97 pt became severely ill-diarrhea, vomiting, joint pain;pt presented to an ER & dx w/gastroenteritis;
Severe hives  all over body 3 days after vaccination and unable to be controlled. Sought medical treatment on Monday 4/5. Initial steroid dosage wasn't working so had to increase, benadryl round the clock, pepcid and Allegra 2x a day.
Chills, muscle aches for 16 hours, fever (102), headache, fatigue lasting 3 days
Acute chest pains in the upper right of chest; Lymph node swelling; Fatigue; Headache; This is a spontaneous report from a non-contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0182) via an unspecified route of administration in the left arm on 14May2021 at 16:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient had no known allergies to medications, food or other products. Concomitant medication included ibuprofen (ADVIL); taken for unknown indication from 10May2021 (4 days prior to second dose). The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the left  arm on 23Apr2021 at 15:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15May2021 at 11:00, the patient experienced unusual side effects acute chest pains in the upper right of chest that occurred sporadically and lymph node swelling. Usual side effects also included fatigue and headache. The events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events. The clinical outcome of the events acute chest pains in the upper right of chest, lymph node swelling, fatigue and headache was not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected.
COVID 19 Treatment; COVID 19 Treatment; Moderna; Pfizer / BioNTech; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 70-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 22Oct2022 as dose 5 (booster), single (Lot number: GJ2524) at the age of 70 years, in left arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 19Jan2021 as dose 1, single (Lot number: 013L20A), in left arm, on 16Feb2021 as dose 2, single (Lot number: 016M20A), on 03Nov2021 as dose 3 (booster), single (Lot number: 039P21A), in left arm and on 13May2022 as dose 4 (booster), single (Lot number: 002MJ 2), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: Penicillin" (unspecified if ongoing). Concomitant medication(s) included: CALCIUM SUPPLEMENT WITH VITAMIN D, start date: 01Jan2010; ROSUVASTATIN, start date: 24Apr2021, stop date: 29Nov2022. Past drug history included: Duricef, reaction(s): "Known allergies: Duricef".  The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 22Oct2022, outcome "unknown", described as "Moderna; Pfizer / BioNTech"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19 with Paxlovid from 29Nov2022 to  03Dec2022.
Dizziness; Trigeminal neuralgia on left side of neck and face; This is a spontaneous report from a contactable consumer (patient). A 62-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: not reported) via an unspecified route of administration in left arm on 25Mar2021 at 13:15 (at the age of 62 years) as dose 1, single and received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EW0172) via an unspecified route of administration in left arm on 11May2021 at 16:00 as dose 2, single for COVID-19 immunization in a hospital. Medical history included elevated blood pressure and penicillin allergy. Patient was not tested COVID prior and post vaccination. Concomitant medication included lisinopril (LISINOPRIL) 15mg. Patient did not receive any other vaccine within four weeks. On 08May2021 at 20:00, the patient experienced dizziness, trigeminal neuralgia on left side of neck and face. The adverse events resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. Steroid blast (7 days prescription) was taken as therapeutic measures as a result of the events. Outcome of the events was recovering.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Patient experienced vasovagal syncope just minutes after receiving her second Pfizer Covid-19 vaccine and the seasonal influenza vaccine together.   She was standing in our vaccine waiting area and fell hitting her head on the concrete floor, but did regain consciousness immediately.  Emergency services was contacted immediately and they arrived 10 to 15 minutes later.  The EMT examined her and felt it was not absolutely necessary she go to the emergency room as she remained alert and responsive.  We told her mother signs and symptoms of concussion to be watchful for over the next 3 to 4 days and to report to the ER if her status changes.
Injection site soreness after 3 hours, no redness or swelling After 9 hours slight nausea (ate only a few crackers and 2 slices of cheese) After 10 hours chills and fever of 102, redness across chest and neck, back pain, significant aching of all muscles in arms and legs, slight dizziness and slight blurred vision (no rash and no significant redness at injection site), slightly elevated heart rate and some tightness in chest After 12 hours fever of 101, after taking 1000mg acetaminophen, persistence of previous symptoms After 16 hours, onset of urinary tract infection symptoms--need to urinate, stinging--persisting over the next 5 hours (feeling need to urinate every 20 minutes), little sleep (drinking green tea), other symptoms subsided After 21 hours bad headache, treated with 1,000mg acetaminophen After 24 hours symptoms subsided, fever of 100.8 and dropping After 28 hours temperature normal, general weakness persists After 43 hours UTI-like symptoms persist, pain in bladder area and lower back, slight headache